Beximco Pharmaceuticals Ltd has disclosed its unaudited earnings report for the third Quarter (January ’23-March’23)..
The report was released after reviewing and approving the company's board meeting held on Saturday (April 29).
As per the disclosure, (January ’23-March’23) its earnings per share (EPS) has been Tk 2.13 for against one year at the same time earnings per share (EPS) was Tk 2.47.
Last 9 months (July’22- March’23) has been Tk 8.15 for against one year earnings per share (EPS)was Tk 9.60.
nj